The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader).

If you would like more information about how to print, save, and work with PDFs, Highwire Press provides a helpful Frequently Asked Questions about PDFs.

Alternatively, you can download the PDF file directly to your computer, from where it can be opened using a PDF reader. To download the PDF, click the Download link above.

Fullscreen Fullscreen Off


This article provides an overview of current drug shortages in the United States as of November 5, 2011. IMS report finds cancer drugs and generic injectables are scarcest, calls for early warning system to prevent shortages from disrupting patient care. Shortages are worst among a handful of 75 drugs, including biologicals, vitamins, antibiotics, antiemetics, antihypertensive agents, narcotic analgesics and CNS drugs. Most of the drugs on the list are generic intravenous or injectable drugs given to patients in hospitals. Manufacturers voluntarily report shortages to FDA. There are several reasons for current drug shortages. A major reason for these shortages is quality/manufacturing issues and growing demand for these drug products. Drug shortage is a long-standing problem inthe US and in many countries worldwide. There is a great need to develop a plan addressing this critical issue.

Keywords

Drug shortage; APIs; antibiotics; anticancer agents; biologicals; supplements
User
Notifications
Font Size